Skip to main content
. 2019 Oct 3;221(5):721–728. doi: 10.1093/infdis/jiz508

Table 2.

Univariate and Multivariate Logistic Regression Analysis of Determinants of Seropositivity at Enrollment

Determinants Univariate Analysis Multivariate Analysis
OR (95% CI) P Value aOR (95% CI) P Value
Age at enrollment, y .97 (.92–1.02) .194
Sex (male vs female) .9 (.7–1.1) .311
Age at the first dose of routine MMR vaccination
 ≤15 mo (baseline) 1.00 1.00
 16–23 mo 1.21 (.89–1.65) .225 1.17 (.86–1.60) .319
 ≥24 mo 2.22 (1.55–3.18) < .0001 1.49 (.95–2.32) .080
Age, y, at the second dose of routine MMR vaccine 1.05 (1.02–1.09) .005 1.01 (.94–1.09) .753
Time, mo, from the first to second dose of MMR vaccine 1.00 (.99–1.00) .019 .99 (.99–1.00) .014
Time, mo, from the first dose of MMR vaccine to antibody titer evaluation .99 (.98–.99) < .0001 a
Time, mo, from the second dose of MMR vaccine to antibody titer evaluation .99 (.98–.99) < .0001 .99 (.98–.99) < .0001

Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; MMR, measles-mumps-rubella; OR, odds ratio.

aOmitted because of collinearity; Hosmer–Lemeshow χ 2 = 5.1 (P = .747).